SCHEMBL30483844

SCHEMBL30483844

c1ccc2c(c1)Nc1ccccc1C21CCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 1/20 0.48
▸ BACE1 P56817 1/20 0.47
▸ OPRM1 P35372 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ OPRL1 P41146 1/20 0.41
▸ PGR P06401 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HTR2A P28223 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PDK2 Q15119 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13827560 0.98 PDE7A (0.52) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL31606006 0.84 PGR (0.41) PDE7ABACE1PGRMEN1KMT2A
SCHEMBL29387092 0.83 BACE1 (0.64) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL1268479 0.83 BACE1 (0.64) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL7004720 0.81 PDE7A (0.46) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL21537944 0.81 BACE1 (0.62) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL29799132 0.81 BACE1 (0.62) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL1223213 0.81 BACE1 (0.62) PDE7ABACE1OPRM1OPRK1OPRL1
SCHEMBL6838754 0.79 ALDH1A1 (0.42) PDE7AHTR2AALDH1A1
SCHEMBL29609089 0.79 BACE1 (0.64) PDE7ABACE1OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025110809-A1 NOVEL DIHYDROACRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 미토이뮨테라퓨틱스 2025-05-30 — — WO disclosed
US-20240397822-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-11-28 — — US disclosed
WO-2023128688-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2023-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240397822-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME OR10J3, PER2, LIMS1 PDE7A 4026/4885BACE1 422/4885OPRM1 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback